Product Description

Addyi Tablets (Flibanserin) – The First FDA-Approved Pill for Women’s Sexual Health

Addyi works by balancing neurotransmitters in the brain that affect sexual interest. Unlike male sexual health treatments, Addyi targets female libido concerns, helping women regain confidence and desire in their intimate relationships. Addyi Tablets, also known as Flibanserin, is a groundbreaking medication specifically designed to treat Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women. This condition is characterized by a persistent lack of sexual desire that can cause distress or interpersonal issues. Addyi helps improve sexual desire by targeting neurotransmitters in the brain, making it a unique and first-of-its-kind solution for women struggling with low libido.

Ingredients:

Microcrystalline Cellulose:

Function: Acts as a binder and filler to provide structure to the tablet.

Lactose Monohydrate:

Function: Used as a filler to add bulk to the tablet.

Croscarmellose Sodium:

Function: Helps the tablet disintegrate quickly, ensuring that the active ingredient is absorbed effectively.

Magnesium Stearate:

Function: Acts as a lubricant to ensure smooth tablet manufacturing and prevents sticking to the equipment.

Silicon Dioxide:

Function: Serves as an anti-caking agent, preventing clumping during production.

Hypromellose:

Function: Used in the coating of the tablet, helping it dissolve at the correct rate.

Talc:

Function: Serves as a glidant, helping with the tablet’s flow during manufacturing.

Titanium Dioxide:

Function: Used as a white pigment in the coating of the tablet to provide color.

Benefit.

Premenopausal Women with HSDD:

Addyi is specifically designed for premenopausal women experiencing low sexual desire. It is not suitable for men or postmenopausal women.

Women Seeking a Non-Hormonal Solution:

Women who prefer not to use hormone-based therapies for libido improvement can benefit from Addyi, as it works on brain chemicals rather than hormones.